TY - JOUR
T1 - Socio-demographic factors, health risks and harms associated with early initiation of injection among people who inject drugs in Tallinn, Estonia
T2 - Evidence from cross-sectional surveys
AU - Vorobjov, Sigrid
AU - Des Jarlais, Don C.
AU - Abel-Ollo, Katri
AU - Talu, Ave
AU - Rüütel, Kristi
AU - Uusküla, Anneli
N1 - Funding Information:
The study was supported by the Civilian Research Development Foundation grant ESBI-7002-TR-08 and by NIH grant R01 AI0832035 , and by Target Financing of Estonian Ministry of Education and Research grant SF0180060s09 . Also by European Commission funded project: Expanding Network for Comprehensive and Coordinated Action on HIV/AIDS prevention among IDUs and Bridging Population (ENCAP) No. 2005305, Global Fund to Fight HIV, Tuberculosis and Malaria Program called “Scaling up the response to HIV in Estonia” for 2003–2007 (grant EST-202-G01-H-00) and National HIV/AIDS Strategy for 2006–2015.
PY - 2013/3
Y1 - 2013/3
N2 - Aim: To explore socio-demographic factors, health risks and harms associated with early initiation of injecting (before age 16) among injecting drug users (IDUs) in Tallinn, Estonia. Methods: IDUs were recruited using respondent driven sampling methods for two cross-sectional interviewer-administered surveys (in 2007 and 2009). Bivariate and multivariate logistic regression analysis was used to identify factors associated with early initiation versus later initiation. Results: A total of 672 current IDUs reported the age when they started to inject drugs; the mean was 18 years, and about a quarter of the sample (. n=. 156) reported early initiation into injecting drugs. Factors significantly associated in multivariate analysis with early initiation were being female, having a lower educational level, being unemployed, shorter time between first drug use and injecting, high-risk injecting (sharing syringes and paraphernalia, injecting more than once a day), involvement in syringe exchange attendance and getting syringes from outreach workers, and two-fold higher risk of HIV seropositivity. Conclusions: Our results document significant adverse health consequences (including higher risk behaviour and HIV seropositivity) associated with early initiation into drug injecting and emphasize the need for comprehensive prevention programs and early intervention efforts targeting youth at risk. Our findings suggest that interventions designed to delay the age of starting drug use, including injecting drug use, can contribute to reducing risk behaviour and HIV prevalence among IDUs.
AB - Aim: To explore socio-demographic factors, health risks and harms associated with early initiation of injecting (before age 16) among injecting drug users (IDUs) in Tallinn, Estonia. Methods: IDUs were recruited using respondent driven sampling methods for two cross-sectional interviewer-administered surveys (in 2007 and 2009). Bivariate and multivariate logistic regression analysis was used to identify factors associated with early initiation versus later initiation. Results: A total of 672 current IDUs reported the age when they started to inject drugs; the mean was 18 years, and about a quarter of the sample (. n=. 156) reported early initiation into injecting drugs. Factors significantly associated in multivariate analysis with early initiation were being female, having a lower educational level, being unemployed, shorter time between first drug use and injecting, high-risk injecting (sharing syringes and paraphernalia, injecting more than once a day), involvement in syringe exchange attendance and getting syringes from outreach workers, and two-fold higher risk of HIV seropositivity. Conclusions: Our results document significant adverse health consequences (including higher risk behaviour and HIV seropositivity) associated with early initiation into drug injecting and emphasize the need for comprehensive prevention programs and early intervention efforts targeting youth at risk. Our findings suggest that interventions designed to delay the age of starting drug use, including injecting drug use, can contribute to reducing risk behaviour and HIV prevalence among IDUs.
KW - Adolescents
KW - Eastern Europe
KW - HIV
KW - Injecting drug use
KW - Respondent driven sampling
KW - Risk behaviour
UR - http://www.scopus.com/inward/record.url?scp=84875378467&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84875378467&partnerID=8YFLogxK
U2 - 10.1016/j.drugpo.2012.08.003
DO - 10.1016/j.drugpo.2012.08.003
M3 - Article
C2 - 23036651
AN - SCOPUS:84875378467
SN - 0955-3959
VL - 24
SP - 150
EP - 155
JO - International Journal of Drug Policy
JF - International Journal of Drug Policy
IS - 2
ER -